UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose‐ and time‐dependent manner

Clinical and experimental immunology, 2018-07, Vol.193 (1), p.64-72

2018

Volltextzugriff (PDF)

Imatinib inhibits T-cell receptor–mediated T-cell proliferation and activation in a dose-dependent manner

Blood, 2005-03, Vol.105 (6), p.2473-2479

2005

Volltextzugriff (PDF)

Expansion of highly differentiated CD8 T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation

Leukemia, 2011-10, Vol.25 (10), p.1587-1597

2011

Volltextzugriff (PDF)

Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update

Cytotherapy (Oxford, England), 2008-01, Vol.10 (6), p.633-641

2008

Volltextzugriff (PDF)

A new direction for gene therapy: intrathymic T cell-specific lentiviral gene transfer

The Journal of clinical investigation, 2005-08, Vol.115 (8), p.2064-2067

2005

Volltextzugriff (PDF)

Functional characterization of podia formation in normal and malignant hematopoietic cells

Journal of leukocyte biology, 2002-03, Vol.71 (3), p.425-432

2002

Volltextzugriff (PDF)

Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy

Blood, 2010-08, Vol.116 (5), p.772-782

2010

Volltextzugriff (PDF)

Seltene Ursache eines schmerzlosen Ikterus bei einer 38 Jahre alten Patientin

Die Gastroenterologie, 2024-05, Vol.19 (3), p.242-246

2024

Volltextzugriff (PDF)

Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers

Journal of immunological methods, 2009-01, Vol.340 (1), p.11-24

2009

Volltextzugriff (PDF)

It's moving day: factors affecting peripheral blood stem mobilization and strategies for improvement

British journal of haematology, 2003-08, Vol.122 (3), p.360-375

2003

Volltextzugriff (PDF)

Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque

Blood, 2006-05, Vol.107 (10), p.3865-3867

2006

Volltextzugriff (PDF)

Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques

Blood, 2007-07, Vol.110 (1), p.441-449

2007

Volltextzugriff (PDF)

Remarkable response to rituximab in a patient with atypical CD20(++) mantle cell lymphoma of the bone marrow leading to severe pancytopenia

Annals of hematology, 2004-05, Vol.83 (5), p.316-318

2004

Volltextzugriff (PDF)

A case of severe refractory thrombotic thrombocytic purpura responding to treatment with 13‐CIS retinoic acid

British journal of haematology, 2002-04, Vol.117 (1), p.249-250

2002

Volltextzugriff (PDF)

Expansion of highly differentiated [CD8.sup.+] T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation

Leukemia, 2011-10, Vol.25 (10), p.1587

2011

Volltextzugriff (PDF)

Expansion of highly differentiated CD8 super(+) T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation

Leukemia, 2011-10, Vol.25 (10), p.1587-1597

2011

Volltextzugriff (PDF)

STAT6 and the regulation of CD23 expression in B-chronic lymphocytic leukemia

Leukemia research, 2000-04, Vol.24 (4), p.331-337

2000

Volltextzugriff (PDF)

Phase I safety and pharmacology study of the EpCAM/CD3-bispecific BiTE antibody MT110 in patients with metastatic colorectal, gastric, or lung cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.2573-2573

2010

Volltextzugriff (PDF)

Kinetics of Peripheral Blood Stem Cell Mobilization Following G‐CSF‐Supported Chemotherapy

Stem cells (Dayton, Ohio), 2003-01, Vol.21 (5), p.568-574

2003

Volltextzugriff (PDF)

The impact of low-dose busulfan on clonal dynamics in nonhuman primates

Blood, 2004-09, Vol.104 (5), p.1273-1280

2004

Volltextzugriff (PDF)

Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia

Experimental hematology, 2012-11, Vol.40 (11), p.906-913.e1

2012

Volltextzugriff (PDF)

Old before its time: age-related thymic dysfunction may preclude efficacy of gene therapy in older SCID-X1 patients

Blood, 2005-06, Vol.105 (11), p.4160-4161

2005

Volltextzugriff (PDF)

Phase I Study of the Pi3K Inhibitor Byl719, As a Single Agent in Patients with Advanced Solid Tumors (Ast)

Annals of oncology, 2014-09, Vol.25, p.iv150

2014

Volltextzugriff (PDF)

451PDPHASE I STUDY OF THE PI3Kα INHIBITOR BYL719, AS A SINGLE AGENT IN PATIENTS WITH ADVANCED SOLID TUMORS (AST)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv150-iv150

2014

Volltextzugriff (PDF)

Abstract P2-16-14: Preliminary safety, pharmacokinetics and anti-tumor activity of BYL719, an alpha-specific PI3K inhibitor in combination with fulvestrant: Results from a phase I study

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.P2-P2-16-14

2013

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Englisch
(83)
Deutsch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sorafenib paradoxically activates the RAS/RAF/ERK pathway in polyclonal human NK cells during expansion and thereby enhances effector functions in a dose‐ and time‐dependent manner

Imatinib inhibits T-cell receptor–mediated T-cell proliferation and activation in a dose-dependent manner

Expansion of highly differentiated CD8 T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation

Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update

A new direction for gene therapy: intrathymic T cell-specific lentiviral gene transfer

Functional characterization of podia formation in normal and malignant hematopoietic cells

Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy

Seltene Ursache eines schmerzlosen Ikterus bei einer 38 Jahre alten Patientin

Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers

It's moving day: factors affecting peripheral blood stem mobilization and strategies for improvement

Acute myeloid leukemia is associated with retroviral gene transfer to hematopoietic progenitor cells in a rhesus macaque

Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques

Remarkable response to rituximab in a patient with atypical CD20(++) mantle cell lymphoma of the bone marrow leading to severe pancytopenia

A case of severe refractory thrombotic thrombocytic purpura responding to treatment with 13‐CIS retinoic acid

Expansion of highly differentiated [CD8.sup.+] T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation

Expansion of highly differentiated CD8 super(+) T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation

STAT6 and the regulation of CD23 expression in B-chronic lymphocytic leukemia

Phase I safety and pharmacology study of the EpCAM/CD3-bispecific BiTE antibody MT110 in patients with metastatic colorectal, gastric, or lung cancer

Kinetics of Peripheral Blood Stem Cell Mobilization Following G‐CSF‐Supported Chemotherapy

The impact of low-dose busulfan on clonal dynamics in nonhuman primates

Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia

Old before its time: age-related thymic dysfunction may preclude efficacy of gene therapy in older SCID-X1 patients

Phase I Study of the Pi3K Inhibitor Byl719, As a Single Agent in Patients with Advanced Solid Tumors (Ast)

451PDPHASE I STUDY OF THE PI3Kα INHIBITOR BYL719, AS A SINGLE AGENT IN PATIENTS WITH ADVANCED SOLID TUMORS (AST)

Abstract P2-16-14: Preliminary safety, pharmacokinetics and anti-tumor activity of BYL719, an alpha-specific PI3K inhibitor in combination with fulvestrant: Results from a phase I study

Suchergebnisse filtern